Primary |
Diabetes Mellitus |
83.3% |
Type 2 Diabetes Mellitus |
16.7% |
|
Platelet Count Decreased |
50.0% |
Hypoglycaemic Coma |
25.0% |
Pancreatitis Acute |
25.0% |
|
Secondary |
Diabetes Mellitus |
42.9% |
Hypertension |
12.2% |
Constipation |
6.1% |
Lung Adenocarcinoma |
6.1% |
Postinfarction Angina |
6.1% |
Glioblastoma Multiforme |
4.1% |
Hypercholesterolaemia |
4.1% |
Rheumatoid Arthritis |
4.1% |
Type 2 Diabetes Mellitus |
4.1% |
Abdominal Distension |
2.0% |
Blood Pressure Inadequately Controlled |
2.0% |
Post Gastric Surgery Syndrome |
2.0% |
Product Used For Unknown Indication |
2.0% |
Prophylaxis |
2.0% |
|
Urinary Retention |
12.5% |
Dialysis |
6.3% |
Drug Hypersensitivity |
6.3% |
Hepatic Function Abnormal |
6.3% |
Hyperkalaemia |
6.3% |
Liver Function Test Abnormal |
6.3% |
Malaise |
6.3% |
Nausea |
6.3% |
Pancytopenia |
6.3% |
Pleural Effusion |
6.3% |
Pneumonia |
6.3% |
Pneumonia Staphylococcal |
6.3% |
Rash |
6.3% |
Vomiting |
6.3% |
Yellow Skin |
6.3% |
|
Concomitant |
Diabetes Mellitus |
21.4% |
Multiple Myeloma |
13.5% |
Type 2 Diabetes Mellitus |
8.3% |
Prophylaxis |
6.6% |
Lung Adenocarcinoma |
5.2% |
Myasthenia Gravis |
5.2% |
Hypertension |
4.8% |
Rheumatoid Arthritis |
4.8% |
Diabetic Retinal Oedema |
3.9% |
Cardiac Failure |
3.5% |
Non-small Cell Lung Cancer |
3.5% |
Hyperphosphataemia |
3.1% |
Diabetes Mellitus Non-insulin-dependent |
2.6% |
Lupus Nephritis |
2.6% |
Lung Squamous Cell Carcinoma Stage Unspecified |
2.2% |
Arteriosclerosis Obliterans |
1.7% |
Drug Use For Unknown Indication |
1.7% |
Helicobacter Infection |
1.7% |
Hypercholesterolaemia |
1.7% |
Non-hodgkin's Lymphoma |
1.7% |
|
Bladder Cancer |
13.8% |
White Blood Cell Count Decreased |
9.6% |
Urinary Tract Infection |
7.4% |
Vomiting |
6.4% |
Pleural Effusion |
5.3% |
Pyrexia |
5.3% |
White Blood Cell Count Increased |
5.3% |
Melaena |
4.3% |
Pneumonia |
4.3% |
Renal Failure Acute |
4.3% |
Schizophrenia |
4.3% |
Weight Increased |
4.3% |
Hypoglycaemia |
3.2% |
Hypotony Of Eye |
3.2% |
Interstitial Lung Disease |
3.2% |
Myocardial Infarction |
3.2% |
Nephrolithiasis |
3.2% |
Pancytopenia |
3.2% |
Renal Impairment |
3.2% |
Respiratory Failure |
3.2% |
|